Tropical Diseases: Prevention, Care and Cure

June 29, 2017

Wellesley, Mass., Jun 29, 2017 – A new BCC Research report examines a growing need for treatment of prevention of tropical diseases and the impact on medical research that is forecast to expand to over $2.6 billion by 2021. The report Global Markets for Neglected Tropical Disease Treatments found that some diseases– such as Ebola and Zika viruses -- are attracting double-digit sales growth, while others are seeing declining investment.

In addition to non-profit agencies and study centers, companies in the sector include GlaxoSmithKline, Merck, Sabin Vaccine Institute, Sanofi-Aventis and Sanofi Pasteur, Takeda, Johnson & Johnson, Bayer and Gilead Sciences. BCC Research found that World Health Organization research and the William and Melinda Gates Foundation are calling for more collaborative platforms such as Drugs for Neglected Diseases Initiative (DNDi). In 2015, the total addressable market for diseases explored in this report totaled $1.4 billion in sales.

Dengue, Malaria or Chagas disease, among other conditions, receive little attention in North America because of their marginalized communities or geographically remote locations. The discovery of Zika in the United States and Caribbean has raised awareness, as diseases spread via travel and cargo that can relocate insects and harmful infections. Also, parasites are growing resistant to mosquito control or existing human medicines – making a need for new treatments more critical.

Research Highlights

  • Malaria deaths declined from 2010-15 but claim more than 425,000 victims annually in addition to lost work and school time.
  • Dengue treatments are expected to see 34 % CAGR through 2021, but Malaria treatment growth is forecast at about 8 % CAGR.
  • The number of disease variants means that not all Malaria or Dengue treatments and versions respond to evolving or resistant virus mutations.

"These diseases have a range of care from prevention to treatment of symptoms to possible vaccinations. The demand is only increasing because travel and spread of infection makes this a worldwide issue – not a regional one that affects remote African or South American areas,” says Robert Hunter, senior healthcare editor atBCC Research. "The 2015 global market for malaria treatment care was about $440 million.”

Editors and reporters who wish to speak with the analyst should contact Steven Cumming at

Global Markets for Neglected Tropical Disease Treatments( PHM180A )
Publish Date: Jun 2017    

Data and analysis extracted from this press release must be accompanied by a statement identifying BCC Research LLC as the source and publisher. For media inquiries, email or visit to request access to our library of market research.